It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
A key challenge of central nervous system tumor surgery is to discriminate between brain regions infiltrated by tumor cells and surrounding healthy tissue. Although monitoring of autofluorescence could potentially be an efficient way to provide reliable information for these regions, we found little information on this subject, and thus we conducted studies of brain tissue optical properties. This particular study focuses on the different optical quantitative responses of human central nervous system tumors and their corresponding controls. Measurements were performed on different fixed human tumoral and healthy brain samples. Four groups of central nervous system tumors (glioblastoma, diffuse glioma, meningioma and metastasis) were discriminated from healthy brain and meninx control tissues. A threshold value was found for the scattering and absorption coefficient between tumoral and healthy groups. Emission Spectra of healthy tissue had a significant higher intensity than tumoral groups. The redox and optical index ratio were thenn calculated and these also showed significant discrimination. Two fluorescent molecules, NADH and porphyrins, showed distinct lifetim values among the different groups of samples. This study defines several optical indexes that can act as combinated indicators to discriminate healthy from tumoral tissues.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 IMNC Laboratory UMR 8165-CNRS/IN2P3, Paris-Saclay University, Orsay, France
2 Neuropathology Department, Sainte-Anne Hospital, Paris, France; IMA BRAIN, INSERMU894, Centre de Psychiatrie et de Neurosciences, Paris, France
3 Neurosurgery Department, Sainte-Anne Hospital, Paris, France; Paris Descates University, Paris, France
4 IMA BRAIN, INSERMU894, Centre de Psychiatrie et de Neurosciences, Paris, France; Neurosurgery Department, Sainte-Anne Hospital, Paris, France; Paris Descates University, Paris, France
5 IMNC Laboratory UMR 8165-CNRS/IN2P3, Paris-Saclay University, Orsay, France; Université Paris Diderot, Sorbonne Paris Cité, Paris, France